Skip to main content

RAS Dialogue

Join the discussion! Post comments, ask questions, and share information with RAS experts. Subscribe to receive notifications when a new RAS Dialogue article is posted.

    • New Clarity on the Warburg Effect
      , by Alba Luengo, Zhaoqi Li, and Matthew Vander Heiden

      Cancer cells divert glucose from ATP-rich oxidative phosphorylation, to ATP-poor glycolysis, which produces lactic acid as a byproduct. New research is revealing the mechanisms regulating the balance between oxidation and glycolysis.

      Continue Reading >

    • Deploying a RAS pipeline against the SARS-CoV-2 pandemic
      , by Dom Esposito

      The NCI RAS Initiative has developed a set of advanced protein expression and purification protocols. Those protocols have been applied to supply antibody and antigen reagents for several SARS-CoV-2 / Covid-19 pandemic research projects.

      Continue Reading >

    • SOS signaling in RAS-mutated cancers
      , by Erin Sheffels and Rob Kortum

      SOS proteins participate in controlling the activity of the RAS pathway, even when RAS itself is mutated and driving cancer. Inhibitors of SOS in combination with other drugs show promise as elements of new cancer therapies.

      Continue Reading >

    • RAS Mutation Tropism
      , by Siqi Li, David MacAlpine, and Christopher M Counter

      The three isoforms of Ras share signaling modalities, yet their cancer-associated mutations vary widely in sequence and the organs affected. Sequencing those mutations very soon after they occur sheds light on the forces driving those differences.

      Continue Reading >

    • The disease burden of Ras
      , by Ian A Prior

      Cancer genome databases yield different estimates of the importance of RAS genes in cancers. Integrating the data that underlie those estimates may suggest new research priorities based on patient numbers.

      Continue Reading >